Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of cyclooxygenase-2 (COX-2) in pituitary tumours.
Sokołowski G, Bałdys-Waligórska A, Trofimiuk M, Adamek D, Hubalewska-Dydejczyk A, Gołkowski F. Sokołowski G, et al. Among authors: trofimiuk m. Med Sci Monit. 2012 Apr;18(4):CR252-9. doi: 10.12659/msm.882625. Med Sci Monit. 2012. PMID: 22460097 Free PMC article.
Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours.
Sowa-Staszczak A, Pach D, Kunikowska J, Krolicki L, Stefanska A, Tomaszuk M, Buziak-Bereza M, Mikolajczak R, Matyja M, Gilis-Januszewska A, Jabrocka-Hybel A, Trofimiuk M, Hubalewska-Dydejczyk A. Sowa-Staszczak A, et al. Among authors: trofimiuk m. Endokrynol Pol. 2011;62(5):392-400. Endokrynol Pol. 2011. PMID: 22069099 Free article.
Repeated cycles of peptide receptor radionuclide therapy (PRRT)--results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET.
Pach D, Sowa-Staszczak A, Kunikowska J, Królicki L, Trofimiuk M, Stefańska A, Tomaszuk M, Głowa B, Mikołajczak R, Pawlak D, Jabrocka-Hybel A, Hubalewska-Dydejczyk AB. Pach D, et al. Among authors: trofimiuk m. Radiother Oncol. 2012 Jan;102(1):45-50. doi: 10.1016/j.radonc.2011.08.006. Epub 2011 Aug 30. Radiother Oncol. 2012. PMID: 21885142
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs).
Sowa-Staszczak A, Pach D, Chrzan R, Trofimiuk M, Stefańska A, Tomaszuk M, Kołodziej M, Mikołajczak R, Pawlak D, Hubalewska-Dydejczyk A. Sowa-Staszczak A, et al. Among authors: trofimiuk m. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1669-74. doi: 10.1007/s00259-011-1835-8. Epub 2011 May 11. Eur J Nucl Med Mol Imaging. 2011. PMID: 21559978 Free PMC article. Clinical Trial.
Neuroendocrine tumours of rare location.
Hubalewska-Dydejczyk A, Trofimiuk M, Sowa-Staszczak A, Gilis-Januszewska A, Baczyńska E, Szybiński P, Anielski R, Matłok M, Bonicki W, Kunikowska J. Hubalewska-Dydejczyk A, et al. Among authors: trofimiuk m. Endokrynol Pol. 2010 May-Jun;61(3):322-7. Endokrynol Pol. 2010. PMID: 20602309 Free article.
[Somatostatin receptors expression (SSTR1-SSTR5) in pheochromocytomas].
Hubalewska-Dydejczyk A, Trofimiuk M, Sowa-Staszczak A, Gilis-Januszewska A, Wierzchowski W, Pach D, Budzyński A, Karcz D. Hubalewska-Dydejczyk A, et al. Among authors: trofimiuk m. Przegl Lek. 2008;65(9):405-7. Przegl Lek. 2008. PMID: 19140390 Review. Polish.
35 results